Benzinga | Sep 22, 2020 10:38AM EDT

Why NanoVibronix's Stock Is Trading Higher Today

NanoVibronix (NASDAQ:NAOV) shares are trading higher on Tuesday after the company announced its UroShield received FDA authorization for entry into the U.S.

NanoVibronix is engaged in the manufacturing of noninvasive biological response-activating devices that target wound healing and pain therapy, without the assistance of medical professionals.

The primary products of the company include WoundShield, which is patch-based therapeutic ultrasound device to facilitate tissue regeneration and wound healing by using ultrasound to increase local capillary perfusion and tissue oxygenation; PainShield, which is a disposable patch-based therapeutic ultrasound technology to treat pain, muscle spasm and joint contractures; and UroShield ,which is an ultrasound-based product designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy and decrease pain.

NanoVibronix shares were trading up 110.24% at $1.24 on Tuesday at the time of publication. The stock has a 52-week high of $3.50 and a 52-week low of 54 cents.